lystn

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.   

 Episode outline:   

• The relationship among systemic inflammation, ASCVD, and CKD 
• The role of cardiologists and nephrologists in screening and mitigating systemic inflammation 

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:   

• CME-certified text module with animated pathophysiology video and faculty voice audio clips 
• ClinicalThought commentaries 
• Podcast episode 2, discussing novel therapeutic approaches to address residual inflammatory risks in patients with ASCVD and CKD 
• Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD